| Q64389285 | A novel mutation avoidance mechanism dependent on S. cerevisiae RAD27 is distinct from DNA mismatch repair |
| Q40954602 | A role for methylation of the hMLH1 promoter in loss of hMLH1 expression and drug resistance in ovarian cancer |
| Q37383704 | APC mutations in colorectal tumors with mismatch repair deficiency |
| Q54561640 | Allele loss in colorectal cancer at the Cowden disease/juvenile polyposis locus on 10q. |
| Q40002286 | Allele loss occurs frequently at hMLH1, but rarely at hMSH2, in sporadic colorectal cancers with microsatellite instability |
| Q37640674 | Allelic imbalance and microsatellite instability of the DCC gene in colorectal cancer in patients under the age of 35 using fluorescent DNA technology |
| Q58068617 | Allelic imbalance at the DNA mismatch repair loci, hMSH2, hMLH1, hPMS1, hPMS2 and hMSH3, in squamous cell carcinoma of the head and neck |
| Q74606005 | Allelic loss on chromosome 18q as a prognostic marker in stage II colorectal cancer |
| Q35758141 | Allelic losses at genomic instability-associated loci in villous adenomas and adjacent colorectal cancers |
| Q36637607 | Alternative genetic pathways in colorectal carcinogenesis. |
| Q36935282 | An Escherichia coli effector protein promotes host mutation via depletion of DNA mismatch repair proteins |
| Q79832402 | An individual with Muir-Torre syndrome found to have a pathogenic MSH6 gene mutation |
| Q74202107 | An intronic germline transition in the HNPCC gene hMSH2 is associated with sporadic colorectal cancer |
| Q57570041 | Analysis of mismatch repair genes in hereditary non–polyposis colorectal cancer patients |
| Q54923501 | Association of replication error positive phenotype with lymphocyte infiltration in endometrial cancers. |
| Q33696650 | Associations of hormone replacement therapy and oral contraceptives with risk of colorectal cancer defined by clinicopathological factors, beta-catenin alterations, expression of cyclin D1, p53, and microsatellite-instability |
| Q33444726 | Attaching and effacing Escherichia coli downregulate DNA mismatch repair protein in vitro and are associated with colorectal adenocarcinomas in humans |
| Q72345825 | BRCA1: more than a hereditary breast cancer gene? |
| Q99546378 | Bacteria-related changes in host DNA methylation and the risk for CRC |
| Q60527157 | Benign and malignant thyroid lesions show instability at microsatellite loci |
| Q35207278 | Betulinic acid inhibits colon cancer cell and tumor growth and induces proteasome-dependent and -independent downregulation of specificity proteins (Sp) transcription factors |
| Q36213486 | Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers. |
| Q27934985 | Binding of insertion/deletion DNA mismatches by the heterodimer of yeast mismatch repair proteins MSH2 and MSH3. |
| Q33703940 | CAG repeat instability, cryptic sequence variation and pathogeneticity: evidence from different loci |
| Q56589948 | CD103+ intraepithelial lymphocytes—a unique population in microsatellite unstable sporadic colorectal cancer |
| Q57337219 | CLINICO-PATHOLOGICAL FEATURES AND p53 EXPRESSION IN LEFT-SIDED SPORADIC COLORECTAL CANCERS WITH AND WITHOUT MICROSATELLITE INSTABILITY |
| Q41332704 | Cancer gets Mad: DPC4 and other TGFbeta pathway genes in human cancer |
| Q58862209 | Causes of microsatellite instability in colorectal tumors |
| Q71970798 | Characterization of MSH2 and MLH1 mutations in Italian families with hereditary nonpolyposis colorectal cancer |
| Q34606398 | Characterization of the repeat-tract instability and mutator phenotypes conferred by a Tn3 insertion in RFC1, the large subunit of the yeast clamp loader |
| Q54576566 | Cleavage of insertion/deletion mismatches, flap and pseudo-Y DNA structures by deoxyinosine 3'-endonuclease from Escherichia coli. |
| Q41875891 | Clinicopathologic Significance of BRAF Mutation and Extracellular Signal Regulated Kinase 1/2 Expression in Patients With a Colorectal Adenocarcinoma |
| Q89868154 | Colon Cancer: A Clinician's Perspective in 2019 |
| Q53977080 | Colorectal carcinogenesis: from chromosomal evolution pathways to molecular pathogenesis. |
| Q28256331 | Combined hereditary and somatic mutations of replication error repair genes result in rapid onset of ultra-hypermutated cancers |
| Q24650948 | Comparative genomics and molecular dynamics of DNA repeats in eukaryotes |
| Q37357197 | Competency in mismatch repair prohibits clonal expansion of cancer cells treated with N-methyl-N'-nitro-N-nitrosoguanidine |
| Q33677624 | Complex genetic predisposition to cancer in an extended HNPCC family with an ancestral hMLH1 mutation. |
| Q34705149 | Concurrent genetic alterations in DNA polymerase proofreading and mismatch repair in human colorectal cancer |
| Q55066383 | CpG dinucleotides in the hMSH2 and hMLH1 genes are hotspots for HNPCC mutations. |
| Q59504153 | Cytogenetic abnormalities and microsatellite instability in endometrial adenocarcinoma |
| Q38859134 | DNA Electrochemistry Shows DNMT1 Methyltransferase Hyperactivity in Colorectal Tumors |
| Q33775559 | DNA aptamers as molecular probes for colorectal cancer study. |
| Q36049856 | DNA methylation and genetic instability in colorectal cancer cells |
| Q34568596 | DNA mismatch repair defects: role in colorectal carcinogenesis |
| Q41561505 | DNA mismatch repair gene mutations in human cancer |
| Q33947053 | DNA mismatch repair genes and colorectal cancer |
| Q52893411 | DNA mismatch repair in lymphoblastoid cells from hereditary non-polyposis colorectal cancer (HNPCC) patients is normal under conditions of rapid cell division and increased mutational load. |
| Q41536289 | DNA mismatch repair in mammals: role in disease and meiosis |
| Q24313002 | DNA polymerase delta is required for human mismatch repair in vitro |
| Q41264767 | DNA repair and colorectal cancer |
| Q38077667 | DNA repair mechanisms in Huntington's disease |
| Q33786528 | Destabilization of yeast micro- and minisatellite DNA sequences by mutations affecting a nuclease involved in Okazaki fragment processing (rad27) and DNA polymerase delta (pol3-t). |
| Q33682850 | Detection of new mutations in six out of 10 Swiss HNPCC families by genomic sequencing of the hMSH2 and hMLH1 genes |
| Q34277292 | Diagnostic and prognostic tumor markers in the gastrointestinal tract. |
| Q38358374 | Differences in the spectrum of spontaneous mutations in the hprt gene between tumor cells of the microsatellite mutator phenotype |
| Q47954900 | Differential expression of hMLH1 and hMSH2 is related to bladder cancer grade, stage and prognosis but not microsatellite instability |
| Q31039347 | Differential expression of the mismatch repair gene hMSH2 in malignant prostate tissue is associated with cancer recurrence |
| Q73446728 | Differential prognosis of replication error phenotype and loss of heterozygosity in sporadic colorectal cancer |
| Q34975498 | Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype |
| Q53341303 | Distinct molecular patterns based on proximal and distal sporadic colorectal cancer: arguments for different mechanisms in the tumorigenesis. |
| Q35361213 | Elevated levels of the pro-carcinogenic adduct, O(6)-methylguanine, in normal DNA from the cancer prone regions of the large bowel |
| Q34571633 | Emerging pathways in colorectal-cancer development |
| Q38837858 | Epigenetic Determinants of Cancer |
| Q33631655 | Epistemology of the origin of cancer: a new paradigm |
| Q61196038 | Evaluation of the replication error phenotype in relation to molecular and clinicopathological features in hereditary and early onset colorectal cancer |
| Q27938608 | Evidence for involvement of yeast proliferating cell nuclear antigen in DNA mismatch repair |
| Q27312240 | Evolution of mutational robustness in the yeast genome: a link to essential genes and meiotic recombination hotspots |
| Q57646224 | Exome-wide analysis of bi-allelic alterations identifies a Lynch phenotype in The Cancer Genome Atlas |
| Q50301547 | Expanded (CAG)n, (CGG)n and (GAA)n trinucleotide repeat microsatellites, and mutant purine synthesis and pigmentation genes cause schizophrenia and autism |
| Q51137586 | Expression of MLH1 and MSH2 in urothelial carcinoma of the renal pelvis. |
| Q74445140 | Expression of hMSH2 and hMLH1 in colorectal carcinomas with microsatellite instability |
| Q47960692 | Extensive but hemiallelic methylation of the hMLH1 promoter region in early-onset sporadic colon cancers with microsatellite instability |
| Q52826936 | Extensive characterization of genetic alterations in a series of human colorectal cancer cell lines. |
| Q36641429 | Extensive molecular screening for hereditary non-polyposis colorectal cancer |
| Q36141256 | Extracolonic features of familial adenomatous polyposis in patients with sporadic colorectal cancer |
| Q41264786 | Familial risk and colorectal cancer |
| Q37730007 | Fine mapping of colon tumor susceptibility (Scc) genes in the mouse, different from the genes known to be somatically mutated in colon cancer |
| Q55018082 | Frameshift mutations and a length polymorphism in the hMSH3 gene and the spectrum of microsatellite instability in sporadic colon cancer. |
| Q24337018 | Frameshift mutations of Wnt pathway genes AXIN2 and TCF7L2 in gastric carcinomas with high microsatellite instability |
| Q77768810 | Frameshift mutations of human gastrin receptor gene (hGARE) in gastrointestinal cancers with microsatellite instability |
| Q35840995 | Frequency of germline hereditary non-polyposis colorectal cancer gene mutations in patients with multiple or early onset colorectal adenomas |
| Q35352538 | Frequency of replication errors in colorectal cancer and their association with family history |
| Q73283874 | Frequent hypermethylation of MLH1 promoter in normal endometrium of patients with endometrial cancers |
| Q52545781 | Frequent impairment of the spindle assembly checkpoint in hepatocellular carcinoma. |
| Q36617588 | Frequent loss of heterozygosity at the DNA mismatch-repair loci hMLH1 and hMSH3 in sporadic breast cancer |
| Q55299149 | Frequent microsatellite instabilities and analyses of the related genes in familial gastric cancers. |
| Q33952944 | Functional significance of concomitant inactivation of hMLH1 and hMSH6 in tumor cells of the microsatellite mutator phenotype. |
| Q33599177 | Gastrointestinal polyposis syndromes |
| Q30470281 | Genes driving the colonoscope. |
| Q40972502 | Genetic alterations in breast cancer. |
| Q47905140 | Genetic alterations in colorectal cancer, comparative analysis of deletion events, and point mutations. |
| Q74234550 | Genetic alterations of sporadic colorectal cancer with microsatellite instability, especially characteristics of primary multiple colorectal cancers |
| Q35810106 | Genetic and epigenetic modification of MLH1 accounts for a major share of microsatellite-unstable colorectal cancers |
| Q58074449 | Genetic and epigenetic modification of mismatch repair genes hMSH2 and hMLH1 in sporadic breast cancer with microsatellite instability |
| Q41514028 | Genetic changes induced by heterocyclic amines |
| Q41355776 | Genetic control of microsatellite stability |
| Q38297232 | Genetic instability occurs in the majority of young patients with colorectal cancer |
| Q35930688 | Genetic predisposition to colorectal cancer |
| Q34008801 | Genetic predisposition to colorectal cancer: where we stand and future perspectives |
| Q37229689 | Genetic prognostic markers in colorectal cancer |
| Q36915541 | Genetic screens to identify pathogenic gene variants in the common cancer predisposition Lynch syndrome |
| Q33764029 | Genetic susceptibility to non-polyposis colorectal cancer |
| Q60300138 | Genomic alterations (LOH, MI) on chromosome 17q21-23 and prognosis of sporadic colorectal cancer |
| Q77847783 | Genomic analysis of the thymine-DNA glycosylase (TDG) gene on 12q22-q24.1 in human pancreatic ductal adenocarcinoma |
| Q54703701 | Genotyping possible polymorphic variants of human mismatch repair genes in healthy Korean individuals and sporadic colorectal cancer patients. |
| Q42005199 | Germline HNPCC gene variants have little influence on the risk for sporadic colorectal cancer |
| Q57978009 | Germline and somatic mutations in hMSH6 and hMSH3 in gastrointestinal cancers of the microsatellite mutator phenotype |
| Q40810320 | Growth inhibition due to complementation of transforming growth factor-beta receptor type II-defect by human chromosome 3 transfer in human colorectal carcinoma cells |
| Q37411879 | Helicobacter pylori infection and expression of DNA mismatch repair proteins |
| Q56928447 | Hereditary breast cancer |
| Q34316225 | Hereditary non-polyposis colorectal cancer syndrome: combined risk of gastrointestinal and gynaecological cancer |
| Q24535557 | Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds |
| Q41045332 | Hereditary nonpolyposis colorectal cancer: review of clinical, molecular genetics, and counseling aspects |
| Q34603478 | Heterogeneity of microsatellite mutations within and between loci, and implications for human demographic histories |
| Q57247926 | Heterozygosity for p53 promotes microsatellite instability and tumorigenesis on a Msh2 deficient background |
| Q74116757 | High frequency of microsatellite instability and loss of mismatch-repair protein expression in patients with double primary tumors of the endometrium and colorectum |
| Q36451916 | Human mismatch repair protein hMutLα is required to repair short slipped-DNAs of trinucleotide repeats |
| Q73519990 | Hydrogen peroxide-induced microsatellite instability in the Escherichia coli K-12 endogenous tonB gene |
| Q38864485 | Identification and characterization of a novel MLH1 genomic rearrangement as the cause of HNPCC in a Tunisian family: evidence for a homologous Alu-mediated recombination |
| Q40969574 | Identification of DNA mismatch repair gene mutations in hereditary nonpolyposis colon cancer patients |
| Q90679214 | Immune checkpoint inhibitors for the treatment of MSI-H/MMR-D colorectal cancer and a perspective on resistance mechanisms |
| Q82661944 | Immunohistochemical investigation of tumorigenic pathways in small intestinal adenocarcinoma: a comparison with colorectal adenocarcinoma |
| Q33620113 | Immunophenotype and molecular characterisation of adenocarcinoma of the small intestine |
| Q36179040 | Importance of MutL homologue MLH1 and MutS homologue MSH2 expression in Turkish patients with sporadic colorectal cancer |
| Q24319995 | Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability |
| Q29615026 | Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma |
| Q37418190 | Influence of anthropometric factors on tumour biological characteristics of colorectal cancer in men and women: a cohort study |
| Q58215326 | Infrequent hMSH2 mutations in sporadic gastric adenocarcinoma with microsatellite instability |
| Q36324227 | Initial assessment of a model relating intratumoral genetic heterogeneity to radiological morphology |
| Q45422890 | Intratumour T cells, their activation status and survival in gastric carcinomas characterised for microsatellite instability and Epstein-Barr virus infection. |
| Q34579284 | Is reduced expression of mismatch repair genes MLH1 and MSH2 in patients with sporadic colorectal cancer related to their prognosis? |
| Q58408875 | Le cancer du côlon: du diagnostic moléculaire à la conduite diagnostique et thérapeutique |
| Q28131788 | Lessons from hereditary colorectal cancer |
| Q28190187 | Lifestyle factors and Ki-ras mutations in colon cancer tumors |
| Q91891548 | Limiting oxidative DNA damage reduces microbe-induced colitis-associated colorectal cancer |
| Q42136714 | Loss of HLTF function promotes intestinal carcinogenesis |
| Q36294915 | Loss of heterozygosity for defined regions on chromosomes 3, 11 and 17 in carcinomas of the uterine cervix |
| Q53388588 | Loss of heterozygosity on chromosome 10q is associated with earlier onset sporadic colorectal adenocarcinoma. |
| Q77534962 | Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability |
| Q34620502 | Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of H19-associated CTCF-binding sites in colorectal cancer |
| Q53412085 | Losses of heterozygosity in oral and oropharyngeal epithelial carcinomas. |
| Q22009114 | MED1, a novel human methyl-CpG-binding endonuclease, interacts with DNA mismatch repair protein MLH1 |
| Q62977773 | MSH2 genomic deletions are a frequent cause of HNPCC |
| Q74455966 | MSI in endometrial carcinoma: absence of MLH1 promoter methylation is associated with increased familial risk for cancers |
| Q48386704 | MSI-L gastric carcinomas share the hMLH1 methylation status of MSI-H carcinomas but not their clinicopathological profile |
| Q35881396 | Majority of hMLH1 mutations responsible for hereditary nonpolyposis colorectal cancer cluster at the exonic region 15-16 |
| Q59944728 | Male infertility, genetic analysis of the DAZ genes on the human Y chromosome and genetic analysis of DNA repair |
| Q28203826 | Male infertility, genetic analysis of the DAZ genes on the human Y chromosome and genetic analysis of DNA repair |
| Q35619996 | Mechanisms of inactivation of mismatch repair genes in human colorectal cancer cell lines: the predominant role of hMLH1. |
| Q39927458 | MethyQESD, a robust and fast method for quantitative methylation analyses in HNPCC diagnostics using formalin-fixed and paraffin-embedded tissue samples |
| Q73911349 | Methylation of the hMLH1 promoter but no hMLH1 mutations in sporadic gastric carcinomas with high-level microsatellite instability |
| Q53384886 | Methylation profile of the MLH1 promoter region and their relationship to colorectal carcinogenesis. |
| Q74141755 | Microsatellite alterations and target gene mutations in the early stages of multiple gastric cancer |
| Q53425970 | Microsatellite instability and aneuploidy rate in young colorectal-cancer patients do not differ significantly from those in older patients. |
| Q53455065 | Microsatellite instability and deletion analysis of chromosome 10 in human prostate cancer. |
| Q36422746 | Microsatellite instability and loss of heterozygosity in mammary carcinoma and its probable precursors |
| Q42557015 | Microsatellite instability and loss of heterozygosity on chromosome 10 in rat mammary tumors induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine |
| Q42112990 | Microsatellite instability and mismatch repair gene inactivation in sporadic pancreatic and colon tumours |
| Q57781643 | Microsatellite instability and mutation analysis of candidate genes in unselected sardinian patients with endometrial carcinoma |
| Q35753493 | Microsatellite instability and mutation of DNA mismatch repair genes in gliomas. |
| Q87065266 | Microsatellite instability and promoter hypermethylation in colorectal cancer in India |
| Q35938600 | Microsatellite instability in Korean patients with gastric adenocarcinoma |
| Q35798312 | Microsatellite instability in adenocarcinomas of the upper gastrointestinal tract. Relation to clinicopathological data and family history |
| Q37388438 | Microsatellite instability in childhood rhabdomyosarcoma is locus specific and correlates with fractional allelic loss |
| Q40782081 | Microsatellite instability in human mammary epithelial cells transformed by heavy ions |
| Q28305319 | Microsatellite instability in human solid tumors |
| Q71010040 | Microsatellite instability in primary and metastatic lung carcinomas |
| Q73758307 | Microsatellite instability in squamous cell carcinoma of head and neck from the Indian patient population |
| Q58493764 | Microsatellite instability induced by hydrogen peroxide in Escherichia coli |
| Q54053592 | Microsatellite instability is associated with genetic alteration but not with low levels of expression of the human mismatch repair proteins hMSH2 and hMLH1. |
| Q74290555 | Microsatellite instability is uncommon in young patients with renal cell carcinoma |
| Q35355631 | Microsatellite instability-a useful diagnostic tool to select patients at high risk for hereditary non-polyposis colorectal cancer: a study in different groups of patients with colorectal cancer |
| Q40483766 | Microsatellite instability. Shifting concepts in tumorigenesis |
| Q34217505 | Microsatellite instability: application in hereditary non-polyposis colorectal cancer. |
| Q54102997 | Microsatellite instability: impact on cancer progression in proximal and distal colorectal cancers. |
| Q78651262 | Microsatellite mutations of transforming growth factor-beta receptor type II and caspase-5 occur in human precursor T-cell lymphoblastic lymphomas/leukemias in vivo but are not associated with hMSH2 or hMLH1 promoter methylation |
| Q41347026 | Mismatch Repair Deficiency in Phenotypically Normal Human Cells |
| Q39731406 | Mismatch repair activity in mammalian mitochondria |
| Q44644581 | Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma. |
| Q33960642 | Mismatch repair processing of carcinogen-DNA adducts triggers apoptosis |
| Q35129256 | Mismatch repair proficiency and in vitro response to 5-fluorouracil |
| Q28271480 | Mismatch repair: mechanisms and relationship to cancer susceptibility |
| Q73115539 | Missense and nonsense mutations in codon 659 of MLH1 cause aberrant splicing of messenger RNA in HNPCC kindreds |
| Q52794464 | Molecular Biomarkers for the Evaluation of Colorectal Cancer. |
| Q40341349 | Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology. |
| Q41686589 | Molecular biology of colorectal cancer |
| Q37032739 | Molecular characterization of late stomal recurrence following total laryngectomy |
| Q40429882 | Molecular foundations of cancer: New targets for intervention |
| Q34145288 | Molecular inversion probe analysis of gene copy alterations reveals distinct categories of colorectal carcinoma |
| Q33857623 | Molecular mechanisms of inactivation of TGF-beta receptors during carcinogenesis |
| Q36291749 | Molecular pathogenesis of sporadic duodenal cancer |
| Q33538447 | Molecular prognostic markers in breast cancer |
| Q43087650 | Morphology of sporadic colorectal cancer with DNA replication errors |
| Q38301649 | Mouse mismatch repair gene Msh2 is not essential for transcription-coupled repair of UV-induced cyclobutane pyrimidine dimers |
| Q54938040 | Multiple primary cancers with microsatellite instability: report of a case. |
| Q73173931 | Multiple sites required for expression in 5'-flanking region of the hMLH1 gene |
| Q28303186 | MutS homologs in mammalian cells |
| Q33861772 | Mutated gene-specific phenotypes of dinucleotide repeat instability in human colorectal carcinoma cell lines deficient in DNA mismatch repair |
| Q34635921 | Mutation frequencies at codon 248 of the p53 tumour suppressor gene are not increased in colon cancer cell lines with the RER+ phenotype |
| Q24318892 | Mutation of MSH3 in endometrial cancer and evidence for its functional role in heteroduplex repair |
| Q55260080 | Mutational analyses of multiple target genes in histologically heterogeneous gastric cancer with microsatellite instability. |
| Q38362311 | Mutational analysis of mismatch repair genes, hMLH1 and hMSH2, in sporadic endometrial carcinomas with microsatellite instability |
| Q71970804 | Mutations in MLH1 are more frequent than in MSH2 in sporadic colorectal cancers with microsatellite instability |
| Q33842093 | Mutations in the MSH3 gene preferentially lead to deletions within tracts of simple repetitive DNA in Saccharomyces cerevisiae |
| Q24320018 | Mutations of mitotic checkpoint genes in human cancers |
| Q28235642 | Mutations predisposing to hereditary nonpolyposis colorectal cancer |
| Q41099814 | Mutator genes and mosaicism in colorectal cancer |
| Q54360036 | Mutator phenotypes of common polymorphisms and missense mutations in MSH2. |
| Q39997545 | No evidence of microsatellite instability in bone tumours |
| Q37219476 | Novel DNA mismatch-repair activity involving YB-1 in human mitochondria |
| Q38937353 | Novel hMSH2, hMSH6 and hMLH1 gene mutations and microsatellite instability in sporadic colorectal cancer |
| Q24649675 | Overexpression of Krüppel-like factor 4 in the human colon cancer cell line RKO leads to reduced tumorigenecity |
| Q54365695 | Overview of Genetic Diagnosis in Cancer. |
| Q28360523 | PCR amplification introduces errors into mononucleotide and dinucleotide repeat sequences |
| Q38892431 | Pan-cancer analysis distinguishes transcriptional changes of aneuploidy from proliferation |
| Q64948819 | Parkinson's disease, amyotrophic lateral sclerosis and spinal muscular atrophy are caused by an unstable (CAG)n trinucleotide repeat microsatellite |
| Q34160157 | Pathogenesis of colorectal cancer |
| Q35594437 | Pathogenicity of missense and splice site mutations in hMSH2 and hMLH1 mismatch repair genes: implications for genetic testing |
| Q28299236 | Polymerase delta variants in RER colorectal tumours |
| Q71824297 | Processing of O6-methylguanine by mismatch correction in human cell extracts |
| Q74372251 | Prognostic relevance of hMLH1, hMSH2, and BAX protein expression in endometrial carcinoma |
| Q38473008 | Prognostic significance of DNA replication errors in young patients with colorectal cancer |
| Q77899578 | Prognostic significance of microsatellite instability in sporadic mucinous colorectal cancers |
| Q40434039 | Progress against cancer |
| Q28303580 | Promoter methylation and immunohistochemical expression of hMLH1 and hMSH2 in sporadic colorectal cancer: a study from India |
| Q35882089 | RNA-based mutation screening in hereditary nonpolyposis colorectal cancer |
| Q74610810 | Reduction in hMSH2 mRNA levels by premature translation termination: implications for mutation screening in hereditary nonpolyposis colorectal cancer |
| Q38999756 | Regulation of DNA Alkylation Damage Repair: Lessons and Therapeutic Opportunities |
| Q35964783 | Relationships between p14ARF Gene Methylation and Clinicopathological Features of Colorectal Cancer: A Meta-Analysis |
| Q35358748 | Replication error phenotype, clinicopathological variables, and patient outcome in Dukes' B stage II (T3,N0,M0) colorectal cancer |
| Q53437948 | Reversal of methylation tolerance by transfer of human chromosome 2. |
| Q24806345 | Role of APC and DNA mismatch repair genes in the development of colorectal cancers |
| Q33867888 | Role of detection of microsatellite instability in Chinese with hereditary nonpolyposis colorectal cancer or ordinary hereditary colorectal cancer |
| Q45150040 | Role of tumor suppressor genes in the development of adult T cell leukemia/lymphoma (ATLL). |
| Q41313487 | Screening of patients with a positive family history of colorectal cancer. |
| Q52831040 | Searching for microsatellite mutations in coding regions in lung, breast, ovarian and colorectal cancers. |
| Q24803238 | Somatic frameshift mutations in the Bloom syndrome BLM gene are frequent in sporadic gastric carcinomas with microsatellite mutator phenotype |
| Q53414620 | Somatic frameshift mutations in the MBD4 gene of sporadic colon cancers with mismatch repair deficiency. |
| Q33795280 | Somatic hypermethylation of MSH2 is a frequent event in Lynch Syndrome colorectal cancers |
| Q40878184 | Somatic mutation of hPMS2 as a possible cause of sporadic human colon cancer with microsatellite instability |
| Q33828926 | TGF-beta receptors and DNA repair genes, coupled targets in a pathway of human colon carcinogenesis |
| Q34786141 | The "comparative growth assay": examining the interplay of anti-cancer agents with cells carrying single gene alterations |
| Q50020930 | The Roles of DNA Methylation in the Stages of Cancer |
| Q33343083 | The association between genetic variants in hMLH1 and hMSH2 and the development of sporadic colorectal cancer in the Danish population |
| Q38037329 | The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistance |
| Q42521462 | The genetic basis of Muir-Torre syndrome includes the hMLH1 locus. |
| Q34989790 | The genetic pathogenesis of colorectal cancer |
| Q73200819 | The genetics of colorectal cancer |
| Q41194136 | The genotype of the human cancer cell: implications for risk analysis. |
| Q24648834 | The homeobox gene CDX2 in colorectal carcinoma: a genetic analysis |
| Q34410886 | The mutation rate and cancer |
| Q36282861 | The role of SOS and flap processing in microsatellite instability in Escherichia coli. |
| Q28274343 | The role of chemotherapy in microsatellite unstable (MSI-H) colorectal cancer |
| Q34636999 | The role of individual susceptibility in cancer burden related to environmental exposure |
| Q41736390 | The role of microsatellite instability in gastric carcinoma |
| Q54642861 | Therapy-related leukemia: clinical characteristics and analysis of new molecular risk factors in 96 adult patients. |
| Q77495206 | Transcripts with splicings of exons 15 and 16 of the hMLH1 gene in normal lymphocytes: implications in RNA-based mutation screening of hereditary non-polyposis colorectal cancer |
| Q50538007 | Transforming growth factor β type II receptor as a marker in diffuse large B cell lymphoma. |
| Q24313221 | Triplet repeat-containing ribosomal protein L14 gene in immortalized human endothelial cell line (t-HUE4) |
| Q30699198 | Truncation of the TGF-beta type II receptor gene results in insensitivity to TGF-beta in human gastric cancer cells |
| Q41625163 | Tumor suppressor genes and human cancer |
| Q24804629 | Two modes of microsatellite instability in human cancer: differential connection of defective DNA mismatch repair to dinucleotide repeat instability. |
| Q30588580 | Value of pedigree/clinical data, immunohistochemistry and microsatellite instability analyses in reducing the cost of determining hMLH1 and hMSH2 gene mutations in patients with colorectal cancer |
| Q47376728 | Variable continental distribution of polymorphisms in the coding regions of DNA-repair genes. |
| Q34321746 | What we could do now: molecular pathology of colorectal cancer |
| Q52956515 | Why do mammalian mitochondria possess a mismatch repair activity? |
| Q73812889 | [Evaluation of cancer risk through genetic analysis?] |
| Q53414161 | [Explanation of enigmas of the Lynch syndrome thanks to a new carcinogenesis model characterized by an unorthodox initiation process]. |
| Q24323176 | hMSH2 forms specific mispair-binding complexes with hMSH3 and hMSH6 |
| Q38362634 | hMSH2-independent DNA mismatch recognition by human proteins |